Matches in Nanopublications for { ?s ?p "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1217109.RAWowBJo08TBivHWVzFZPzJvGIReBP-nOsE83ddligooQ130_assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217109.RAWowBJo08TBivHWVzFZPzJvGIReBP-nOsE83ddligooQ130_provenance.
- NP1217104.RAA8BC4rxY9ZhxapIXt9xj2XfT2puK_bOjsAl6r2Lt_kM130_assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217104.RAA8BC4rxY9ZhxapIXt9xj2XfT2puK_bOjsAl6r2Lt_kM130_provenance.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.
- NP1217107.RALenvr6iMLZw_7NlvpKfe_UZaGhOrQAY78hpUidi10Ds130_assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217107.RALenvr6iMLZw_7NlvpKfe_UZaGhOrQAY78hpUidi10Ds130_provenance.